Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Januar 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • troldmandenT Offline
    troldmandenT Offline
    troldmanden
    wrote on sidst redigeret af
    #727

    Kursen er vel tæt på at ligge over snit af analytikernes targets. Så enten skal analytikerne til at hæve yderligere, eller også skal de til at sige hold.

    1 Reply Last reply
    0
    • DarvinD Offline
      DarvinD Offline
      Darvin
      wrote on sidst redigeret af
      #728

      Giv dem tid, de skal jo lige regne på det. Snittet på de nyeste 5, som alle er fra 2021, men før godkendelsen er indtil videre på 2.839 - eller skal vi bare sige over de 2.800 🙂 ($kurs) og så er der lige MS som bekræfter et mål der er lidt under kursen idag.

      1 Reply Last reply
      0
      • troldmandenT Offline
        troldmandenT Offline
        troldmanden
        wrote on sidst redigeret af
        #729

        der er vel noget i retningen af 15 analyser der ikke er ældre end 2 mdrs tid.

        1 Reply Last reply
        0
        • D Offline
          D Offline
          Doublo
          wrote on sidst redigeret af
          #730

          MS's gamle kursmål der lige skulle luftes i dag
          , er på 41$ svarende til 2500, det er vist en mild underdrivelse, at kalde det "lidt under"

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #731

            small new trial: FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia https://clinicaltrials.gov/ct2/show/NCT04714372 https://fatetherapeutics.com/pipeline/immuno-oncology-candidates/ft538/

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #732

              Genmab's neighbour Merus NV Announce Collaboration with Lilly to research and develop up to three CD3-engaging T-cell re-directing bispecific antibody therapies. https://ir.merus.nl/news-releases/news-release-details/lilly-and-merus-nv-announce-collaboration-discover-novel-t-cell

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #733

                Ritzau: https://www.proinvestor.com/investornyt/671252/eli-lilly-indgar-nyt-udviklingssamarbejde-med-milliardpotentiale

                1 Reply Last reply
                0
                • Legolas23L Offline
                  Legolas23L Offline
                  Legolas23
                  wrote on sidst redigeret af
                  #734

                  US gør det de skal..

                  1 Reply Last reply
                  0
                  • Legolas23L Offline
                    Legolas23L Offline
                    Legolas23
                    wrote on sidst redigeret af
                    #735

                    Det ligner der blev indsendt RTOR Amivantamab i starten af december, så mon ikke den tidligst kommer midt februar.

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #736

                      Hvor er du stødt på RTOR? Jeg har ikke kunnet finde noget om det.

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        GeorgeBest
                        wrote on sidst redigeret af
                        #737

                        https://www.jnj.com/janssen-submits-application-to-u-s-fda-seeking-approval-of-amivantamab-for-the-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations
                        Nej, der er vist ikke RTOR på Amivantamab. Det var en fejl fra min side. Her JNJs pm

                        1 Reply Last reply
                        0
                        • Legolas23L Offline
                          Legolas23L Offline
                          Legolas23
                          wrote on sidst redigeret af
                          #738

                          Er der ikke søgt på et ph2 ?

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            GeorgeBest
                            wrote on sidst redigeret af
                            #739

                            Nej, på ph1 studie ved navn CHRYSALIS

                            1 Reply Last reply
                            0
                            • Legolas23L Offline
                              Legolas23L Offline
                              Legolas23
                              wrote on sidst redigeret af
                              #740

                              Troede ikke man kunne søge på ph1

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                mobbyduck1
                                wrote on sidst redigeret af
                                #741

                                hvad forventer vi den 26/1 mht Kesimpta?? Er der nogen ide om, hvor højt salget er
                                ??

                                1 Reply Last reply
                                0
                                • M Offline
                                  M Offline
                                  mobbyduck1
                                  wrote on sidst redigeret af
                                  #742

                                  for q4

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    GeorgeBest
                                    wrote on sidst redigeret af
                                    #743

                                    Er Novartis begyndt kræve betaling?

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #744

                                      I think it will be a very small amount, since Novartis was giving Kesimpta away for free at the start:

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #745

                                        27/10 12:57
                                        af E L
                                        To provide access to eligible US patients while they obtain reimbursement we are providing Kesimpta free of charge for a limited amount of time. Based on our assumption on the time from initiation of therapy to reimbursement we anticipate that a majority of the sales in the first quarter of launch will be free goods and have accrued accordingly. We expect this share to decrease over time as reimbursement progresses

                                        1 Reply Last reply
                                        0
                                        • M Offline
                                          M Offline
                                          mobbyduck1
                                          wrote on sidst redigeret af
                                          #746

                                          ok thx

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger